(NASDAQ:ACIC), Company to Host Quarterly Conference Call at 5:00 P.M. ET on November 5, 2025The information in this press release should be read in conjunction with an earnings presentation that is available on the Company's website at investors.amcoastal.com/events-and-presentations. ST. PETERSBURG, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) — American Coastal Insurance Corporation (Nasdaq: ACIC) (“ACIC” or […]

Enovix Announces Third Quarter 2025 Financial Results Lead Smartphone Customer Advances Toward Commercialization of Enovix's AI-1(TM) Battery Technology; Strengthened Balance Sheet Through Disciplined Capital Markets Execution GlobeNewswire November 05, 2025 FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — Enovix Corporation (Nasdaq: ENVX) (“Enovix”), a global high-performance battery company, announced its third quarter 2025 results. The

(PinkSheets:BSEM),(Pinksheets:BSEM), POMPANO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in placental-derived biologics for advanced wound care, today commented on the Centers for Medicare & Medicaid Services' (“CMS”) Calendar Year 2026 Physician Fee Schedule (PFS) final rule, which reforms Medicare reimbursement for skin substitutes. “CMS's

(NASDAQ:LSAK),(Johannesburg:LSK.JO), JOHANNESBURG, Nov. 05, 2025 (GLOBE NEWSWIRE) — Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the first quarter of fiscal 2026 (“Q1 2026”). Q1 2026 performance1:All growth rates are year-on-year between Q1 FY2026 and Q1 FY2025. Revenue of $171.5 million (ZAR 3.0 billion) up 10% in ZAR. Net Revenue2 of $86.6

Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results GlobeNewswire November 05, 2025 SEATTLE, Nov. 05, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for

Remitly Reports Third Quarter 2025 Results Above Outlook and Raises Full Year 2025 Outlook GlobeNewswire November 05, 2025 Third quarter send volume up 35% and revenue up 25% year over yearThird quarter net income was $8.8 million and Adjusted EBITDA was $61.2 million SEATTLE, Nov. 05, 2025 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY),

(NASDAQ:ADPT), SEATTLE, Nov. 05, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended September 30, 2025. “Our third quarter results reflect

The Honest Company Reports Third Quarter 2025 Results and Transformation 2.0: Powering Honest Growth GlobeNewswire November 05, 2025 Achieves Quarterly Revenue of $93 Million and Delivers Positive Net Income of $1 Million Announces Launch of Transformation 2.0: Powering Honest Growth, Simplifying Business Model toFocus on Strategic Growth Areas and Exit Certain Lower Margin, Non-Strategic Categories

(NASDAQ:RELY), Third quarter send volume up 35% and revenue up 25% year over yearThird quarter net income was $8.8 million and Adjusted EBITDA was $61.2 million SEATTLE, Nov. 05, 2025 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY), a trusted provider of digital financial services that transcend borders, reported results for the third quarter ended

Crane NXT Reports Third Quarter 2025 Results Delivers sales growth of 10%; Narrows full year EPS guidance to $4.00 to $4.10 GlobeNewswire November 05, 2025 WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) — Crane NXT, Co. (NYSE: CXT) (“Crane NXT” or the “Company”), a premier industrial technology company, today announced its financial results for the